<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34510431</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2249</ISSN><JournalIssue CitedMedium="Internet"><Volume>206</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical and experimental immunology</Title><ISOAbbreviation>Clin Exp Immunol</ISOAbbreviation></Journal><ArticleTitle>Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>301</StartPage><EndPage>313</EndPage><MedlinePgn>301-313</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cei.13660</ELocationID><Abstract><AbstractText>Neuropathology studies of amyotrophic lateral sclerosis (ALS) and animal models of ALS reveal a strong association between aberrant protein accumulation and motor neurone damage, as well as activated microglia and astrocytes. While the role of neuroinflammation in the pathology of ALS is unclear, imaging studies of the central nervous system (CNS) support the idea that innate immune activation occurs early in disease in both humans and rodent models of ALS. In addition, emerging studies also reveal changes in monocytes, macrophages and lymphocytes in peripheral blood as well as at the neuromuscular junction. To more clearly understand the association of neuroinflammation (innate and adaptive) with disease progression, the use of biomarkers and imaging modalities allow monitoring of immune parameters in the disease process. Such approaches are important for patient stratification, selection and inclusion in clinical trials, as well as to provide readouts of response to therapy. Here, we discuss the different imaging modalities, e.g. magnetic resonance imaging, magnetic resonance spectroscopy and positron emission tomography as well as other approaches, including biomarkers of inflammation in ALS, that aid the understanding of the underlying immune mechanisms associated with motor neurone degeneration in ALS.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Clinical &amp; Experimental Immunology published by John Wiley &amp; Sons Ltd on behalf of British Society for Immunology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amor</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-6169-9845</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience and Trauma, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nutma</LastName><ForeName>Erik</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzin</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology, Amsterdam UMC Location VUmc, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puentes</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neuroscience and Trauma, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Exp Immunol</MedlineTA><NlmUniqueID>0057202</NlmUniqueID><ISSNLinking>0009-9104</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="Y">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049268" MajorTopicYN="N">Positron-Emission Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TSPO PET</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">central nervous system</Keyword><Keyword MajorTopicYN="N">imaging</Keyword><Keyword MajorTopicYN="N">innate immune system</Keyword><Keyword MajorTopicYN="N">microglia</Keyword></KeywordList><CoiStatement>All authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>12</Day><Hour>21</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34510431</ArticleId><ArticleId IdType="pmc">PMC8561688</ArticleId><ArticleId IdType="doi">10.1111/cei.13660</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chi&#xf2; A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Achi EY, Rudnicki SA. ALS and frontotemporal dysfunction: a review. Neurol Res Int. 2012;2012:806306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3423946</ArticleId><ArticleId IdType="pubmed">22919484</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H&#x2010;J, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Connolly O, Le Gall L, McCluskey G, Donaghy CG, Duddy WJ, Duguez S. A systematic review of genotype&#x2010;phenotype correlation across cohorts having causal mutations of different genes in ALS. J Pers Med. 2020;10:58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7564886</ArticleId><ArticleId IdType="pubmed">32610599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaspina A, Puentes F, Amor S. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective. Int Immunol. 2015;27:117&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">25344935</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccoli T, Partridge L, Isaacs AM. Ageing as a risk factor for ALS/FTD. Hum Mol Genet. 2017;26(R2):R105&#x2013;R13.</Citation><ArticleIdList><ArticleId IdType="pubmed">28977441</ArticleId></ArticleIdList></Reference><Reference><Citation>Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, et al. Inflammaging and anti&#x2010;inflammaging: the role of cytokines in extreme longevity. Arch Immunol Ther Exp (Warsz). 2016;64:111&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">26658771</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers DR, Zhao W, Wang J, Zhang X, Wen S, Neal D, et al. ALS patients&#x2019; regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight. 2017;2:e89530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5333967</ArticleId><ArticleId IdType="pubmed">28289705</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubiri I, Lombardi V, Bremang M, Mitra V, Nardo G, Adiutori R, et al. Tissue&#x2010;enhanced plasma proteomic analysis for disease stratification in amyotrophic lateral sclerosis. Mol Neurodegener. 2018;13:60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6223075</ArticleId><ArticleId IdType="pubmed">30404656</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, Kliest T, van den Berg LH. Current trends in the clinical trial landscape for amyotrophic lateral sclerosis. Curr Opin Neurol. 2020;33:655&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">32796282</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP&#x2010;43 is a component of ubiquitin&#x2010;positive tau&#x2010;negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y, Katsuno M, Niwa J&#x2010;I, Takagi S, Ishigaki S, Ikenaka K, et al. Loss of TDP&#x2010;43 causes age&#x2010;dependent progressive motor neuron degeneration. Brain. 2013;136(Pt 5):1371&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">23449777</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed Z, L&#xf3;pez&#x2010;Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, et al. Premature polyadenylation&#x2010;mediated loss of stathmin&#x2010;2 is a hallmark of TDP&#x2010;43&#x2010;dependent neurodegeneration. Nat Neurosci. 2019;22:180&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6348009</ArticleId><ArticleId IdType="pubmed">30643298</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Dupre N, Petri S, Strong M, Kriz J, et al. Deregulation of TDP&#x2010;43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB&#x2010;mediated pathogenic pathways. J Exp Med. 2011;208:2429&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Bright F, Chan G, van Hummel A, Ittner LM, Ke YD. TDP&#x2010;43 and inflammation: implications for amyotrophic lateral sclerosis and frontotemporal dementia. Int J Mol Sci. 2021;22:7781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8346169</ArticleId><ArticleId IdType="pubmed">34360544</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JD, Woodruff TM. TDP&#x2010;43 Puts the STING in ALS. Trends Neurosci. 2021;44:81&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">33353765</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicencio E, Beltran S, Labrador L, Manque P, Nassif M, Woehlbier U. Implications of selective autophagy dysfunction for ALS pathology. Cells. 2020;9:381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7072226</ArticleId><ArticleId IdType="pubmed">32046060</ArticleId></ArticleIdList></Reference><Reference><Citation>Clarke BE, Patani R. The microglial component of amyotrophic lateral sclerosis. Brain. 2020;143:3526&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7805793</ArticleId><ArticleId IdType="pubmed">33427296</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe9;land L&#x2010;C, Markovinovic A, Jakovac H, De Marchi F, Bilic E, Mazzini L, et al. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2020;2:fcaa124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7585698</ArticleId><ArticleId IdType="pubmed">33134918</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller AF, Gravel M, Kriz J. Treatment with minocycline after disease onset alters astrocyte reactivity and increases microgliosis in SOD1 mutant mice. Exp Neurol. 2011;228:69&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">21168408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Hadlock KG, Do H, Yu S, Honrada R, Champion S, et al. Gene expression profiling in peripheral blood mononuclear cells from patients with sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol. 2011;230:114&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3448551</ArticleId><ArticleId IdType="pubmed">20884065</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibata N, Kakita A, Takahashi H, Ihara Y, Nobukuni K, Fujimura H, et al. Activation of signal transducer and activator of transcription&#x2010;3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients. Neurodegener Dis. 2009;6:118&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">19372705</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Toledo JB, Van Deerlin VM, Elman L, McCluskey L, Lee V&#x2010;Y, et al. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLOS ONE. 2012;7:e39216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3375234</ArticleId><ArticleId IdType="pubmed">22720079</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaur N, Perner C, Witte OW, Grosskreutz J. The chitinases as biomarkers for amyotrophic lateral sclerosis: signals from the CNS and beyond. Front Neurol. 2020;11:377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267218</ArticleId><ArticleId IdType="pubmed">32536900</ArticleId></ArticleIdList></Reference><Reference><Citation>Almad AA, Doreswamy A, Gross SK, Richard J&#x2010;P, Huo Y, Haughey N, et al. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis. Glia. 2016;64:1154&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5635605</ArticleId><ArticleId IdType="pubmed">27083773</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorter RP, Stephenson J, Nutma E, Anink J, Jonge JC, Baron W, et al. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes. Neuropathol Appl Neurobiol. 2019;45:459&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7379307</ArticleId><ArticleId IdType="pubmed">30346063</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Cheng XI, Zhong S, Zhang X, Liu C, Liu F, et al. Peripheral and central nervous system immune response crosstalk in amyotrophic lateral sclerosis. Front Neurosci. 2020;14:575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308438</ArticleId><ArticleId IdType="pubmed">32612503</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmoy T. T cells in amyotrophic lateral sclerosis. Eur J Neurol. 2008;15:360&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18266871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs M, Trias E, Varela V, Ibarburu S, Beckman JS, Moura IC, et al. CD34 identifies a subset of proliferating microglial cells associated with degenerating motor neurons in ALS. Int J Mol Sci. 2019;20:3880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6720880</ArticleId><ArticleId IdType="pubmed">31395804</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Beers DR, Appel SH. Immune&#x2010;mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis. J Neuroimmune Pharmacol. 2013;8:888&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4126425</ArticleId><ArticleId IdType="pubmed">23881705</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, Gunther R, Akgun K, Hermann A, Ziemssen T. Peripheral proinflammatory Th1/Th17 immune cell shift is linked to disease severity in amyotrophic lateral sclerosis. Sci Rep. 2020;10:5941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7125229</ArticleId><ArticleId IdType="pubmed">32246039</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Beers DR, Wen S, Rivera AL, Toennis KM, Appel JE, et al. Regulatory T&#x2010;lymphocytes mediate amyotrophic lateral sclerosis progression and survival. EMBO Mol Med. 2013;5:64&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3569654</ArticleId><ArticleId IdType="pubmed">23143995</ArticleId></ArticleIdList></Reference><Reference><Citation>Thonhoff JR, Beers DR, Zhao W, Pleitez M, Simpson EP, Berry JD, et al. Expanded autologous regulatory T&#x2010;lymphocyte infusions in ALS: A phase I, first&#x2010;in&#x2010;human study. Neurol Neuroimmunol Neuroinflamm. 2018;5:e465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5961523</ArticleId><ArticleId IdType="pubmed">29845093</ArticleId></ArticleIdList></Reference><Reference><Citation>McGill RB, Steyn FJ, Ngo ST, Thorpe KA, Heggie S, Ruitenberg MJ, et al. Monocytes and neutrophils are associated with clinical features in amyotrophic lateral sclerosis. Brain Commun. 2020;2:fcaa013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530830</ArticleId><ArticleId IdType="pubmed">33033799</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Lee JD, Woodruff TM, Henderson RD. The peripheral immune system and amyotrophic lateral sclerosis. Front Neurol. 2020;11:279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186478</ArticleId><ArticleId IdType="pubmed">32373052</ArticleId></ArticleIdList></Reference><Reference><Citation>Cipollina G, Davari Serej A, Di Nolfi G, Gazzano A, Marsala A, Spatafora MG, et al. Heterogeneity of neuroinflammatory responses in amyotrophic lateral sclerosis: a challenge or an opportunity? Int J Mol Sci. 2020;21:7923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7662281</ArticleId><ArticleId IdType="pubmed">33113845</ArticleId></ArticleIdList></Reference><Reference><Citation>Siokas V, Aloizou A&#x2010;M, Liampas I, Tsouris Z, Mentis A&#x2010;F, Nasios G, et al. Lack of association between TREM2 rs75932628 variant and amyotrophic lateral sclerosis. Mol Biol Rep. 2021;48:2601&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">33826063</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivner MH, Liu S, Quarles B, Fleenor B, Shen C, Pan J, et al. Agrin and low&#x2010;density lipoprotein&#x2010;related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients. Muscle Nerve. 2017;55:430&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5318258</ArticleId><ArticleId IdType="pubmed">27756107</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao M, Koneczny I, Vincent A. Myasthenia gravis with antibodies against muscle specific kinase: an update on clinical features. Pathophysiology and treatment. Front Mol Neurosci. 2020;13:159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7492727</ArticleId><ArticleId IdType="pubmed">32982689</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzartos J, Zisimopoulou P, Tsonis A, Evangelakou P, Rentzos M, Karandreas N, et al. LRP4 antibodies are frequent in serum and CSF from amyotrophic lateral sclerosis patients (S34.004). Neurology. 2015;84.</Citation></Reference><Reference><Citation>Tzartos JS, Zisimopoulou P, Rentzos M, Karandreas N, Zouvelou V, Evangelakou P, et al. LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients. Ann Clin Transl Neurol. 2014;1:80&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4212481</ArticleId><ArticleId IdType="pubmed">25356387</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehanna R, Patton EL Jr, Phan CL, Harati Y. Amyotrophic lateral sclerosis with positive anti&#x2010;acetylcholine receptor antibodies. Case report and review of the literature. J Clin Neuromuscul Dis. 2012;14:82&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">23172389</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai H, Cui L, Guan Y, Liu M, Li X, Huang Y, et al. Amyotrophic lateral sclerosis and myasthenia gravis overlap syndrome: a review of two cases and the associated literature. Front Neurol. 2017;8:218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5439131</ArticleId><ArticleId IdType="pubmed">28588549</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, Kovacs M, King PH, Si Y, Kwon Y, Varela V, et al. Schwann cells orchestrate peripheral nerve inflammation through the expression of CSF1, IL&#x2010;34, and SCF in amyotrophic lateral sclerosis. Glia. 2020;68:1165&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269115</ArticleId><ArticleId IdType="pubmed">31859421</ArticleId></ArticleIdList></Reference><Reference><Citation>Trias E, King PH, Si Y, Kwon Y, Varela V, Ibarburu S, et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight. 2018;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6237484</ArticleId><ArticleId IdType="pubmed">30282815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Chio A, Traynor BJ. Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson J, Amor S. Modelling amyotrophic lateral sclerosis in mice. Drug Discov Today Dis Models. 2017;25&#x2013;26:35&#x2013;44.</Citation></Reference><Reference><Citation>Jara JH, Gen&#xe7; B, Stanford MJ, Pytel P, Roos RP, Weintraub S, et al. Evidence for an early innate immune response in the motor cortex of ALS. J Neuroinflamm. 2017;14:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5485686</ArticleId><ArticleId IdType="pubmed">28651542</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerasekera A, Sima DM, Dresselaers T, Van Huffel S, Van Damme P, Himmelreich U. Non&#x2010;invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1(G93A) mouse model: A (1)H&#x2010;magnetic resonance spectroscopic study. Neuroimage Clin. 2018;20:1092&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6202692</ArticleId><ArticleId IdType="pubmed">30368196</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JQ, Tueckmantel W, Zhu A, Pellegrino D, Brownell AL. Synthesis and preliminary biological evaluation of 3&#x2010;[(18)F]fluoro&#x2010;5&#x2010;(2&#x2010;pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5. Synapse. 2007;61:951&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">17787003</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekiguchi KJ, Shekhtmeyster P, Merten K, Arena A, Cook D, Hoffman E, et al. Imaging large&#x2010;scale cellular activity in spinal cord of freely behaving mice. Nat Commun. 2016;7:11450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4853475</ArticleId><ArticleId IdType="pubmed">27121084</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Costa MM, Allen CE, Higginbottom A, Ramesh T, Shaw PJ, McDermott CJ. A new zebrafish model produced by TILLING of SOD1&#x2010;related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening. Dis Model Mech. 2014;7:73&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3882050</ArticleId><ArticleId IdType="pubmed">24092880</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrice JR, Gregory&#x2010;Evans CY, Shaw CA. Modeling Environmentally&#x2010;Induced Motor Neuron Degeneration in Zebrafish. Sci Rep. 2018;8:4890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5861069</ArticleId><ArticleId IdType="pubmed">29559645</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreisl WC, Kim MJ, Coughlin JM, Henter ID, Owen DR, Innis RB. PET imaging of neuroinflammation in neurological disorders. Lancet Neurol. 2020;19:940&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7912433</ArticleId><ArticleId IdType="pubmed">33098803</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew S, Atassi N. Positron emission tomography molecular imaging biomarkers for amyotrophic lateral sclerosis. Front Neurol. 2019;10:135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6405430</ArticleId><ArticleId IdType="pubmed">30881332</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson A, Engler H, Blomquist G, Scott B, Wall A, Aquilonius S&#x2010;M, et al. Evidence for astrocytosis in ALS demonstrated by [11C](L)&#x2010;deprenyl&#x2010;D2 PET. J Neurol Sci. 2007;255:17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">17346749</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghadery C, Best LA, Pavese N, Tai YF, Strafella AP. PET evaluation of microglial activation in non&#x2010;neurodegenerative brain diseases. Curr Neurol Neurosci Rep. 2019;19:38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6538572</ArticleId><ArticleId IdType="pubmed">31139952</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutma E, Ceyz&#xe9;riat K, Amor S, Tsartsalis S, Millet P, Owen DR, et al. Cellular sources of TSPO expression in healthy and diseased brain. Eur J Nucl Med Mol Imaging. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33433698</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreisl WC, Fujita M, Fujimura Y, Kimura N, Jenko KJ, Kannan P, et al. Comparison of [11C]&#x2010;(R)&#x2010;PK 11195 and [11C] PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: implications for positron emission tomographic imaging of this inflammation biomarker. NeuroImage. 2010;49:2924&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2832854</ArticleId><ArticleId IdType="pubmed">19948230</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, et al. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLOS ONE. 2012;7:e52941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Cagnin A, Turkheimer FE, Miller C, Shaw CE, Brooks DJ, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)&#x2010;PK11195 positron emission tomography study. Neurobiol Dis. 2004;15:601&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfc;rcher NR, Loggia ML, Lawson R, Chonde DB, Izquierdo&#x2010;Garcia D, Yasek JE, et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]&#x2010;PBR28. Neuroimage Clin. 2015;7:409&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310932</ArticleId><ArticleId IdType="pubmed">25685708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratai E&#x2010;M, Alshikho MJ, Z&#xfc;rcher NR, Loggia ML, Cebulla CL, Cernasov P, et al. Integrated imaging of [(11)C]&#x2010;PBR28 PET, MR diffusion and magnetic resonance spectroscopy (1)H&#x2010;MRS in amyotrophic lateral sclerosis. Neuroimage Clin. 2018;20:357&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6092554</ArticleId><ArticleId IdType="pubmed">30112276</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrecht DS, Normandin MD, Shcherbinin S, Wooten DW, Schwarz AJ, Zurcher NR, et al. Pseudoreference Regions for Glial Imaging with (11)C&#x2010;PBR28: Investigation in 2 Clinical Cohorts. J Nucl Med. 2018;59:107&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5750517</ArticleId><ArticleId IdType="pubmed">28818984</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshikho MJ, Zurcher NR, Loggia ML, Cernasov P, Reynolds B, Pijanowski O, et al. Integrated magnetic resonance imaging and [(11) C]&#x2010;PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis. Ann Neurol. 2018;83:1186&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6105567</ArticleId><ArticleId IdType="pubmed">29740862</ArticleId></ArticleIdList></Reference><Reference><Citation>Alshikho MJ, Z&#xfc;rcher NR, Loggia ML, Cernasov P, Chonde DB, Izquierdo Garcia D, et al. Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis. Neurology. 2016;87:2554&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5207001</ArticleId><ArticleId IdType="pubmed">27837005</ArticleId></ArticleIdList></Reference><Reference><Citation>Nutma E, Gebro E, Marzin MC, van der Valk P, Matthews PM, Owen DR, et al. Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain. Glia. 2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8453709</ArticleId><ArticleId IdType="pubmed">34145928</ArticleId></ArticleIdList></Reference><Reference><Citation>Grolez G, Moreau C, Danel&#x2010;Brunaud V, Delmaire C, Lopes R, Pradat PF, et al. The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review. BMC Neurol. 2016;16:155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5002331</ArticleId><ArticleId IdType="pubmed">27567641</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009;73:805&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2739608</ArticleId><ArticleId IdType="pubmed">19738176</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroman PW, Wheeler&#x2010;Kingshott C, Bacon M, Schwab JM, Bosma R, Brooks J, et al. The current state&#x2010;of&#x2010;the&#x2010;art of spinal cord imaging: methods. NeuroImage. 2014;84:1070&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4371133</ArticleId><ArticleId IdType="pubmed">23685159</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma T, Cohen&#x2010;Adad J. Effect of respiration on the B0 field in the human spinal cord at 3T. Magn Reson Med. 2014;72:1629&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">24390654</ArticleId></ArticleIdList></Reference><Reference><Citation>Walhout R, Westeneng H&#x2010;J, Verstraete E, Hendrikse J, Veldink JH, van den Heuvel MP, et al. Cortical thickness in ALS: towards a marker for upper motor neuron involvement. J Neurol Neurosurg Psychiatry. 2015;86:288&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">25121571</ArticleId></ArticleIdList></Reference><Reference><Citation>Sage CA, Peeters RR, Gorner A, Robberecht W, Sunaert S. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. NeuroImage. 2007;34:486&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">17097892</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto RG, Weissmann C, Amin M, Finkielsztein A, Sumagin R, Mareci TH, et al. Assessing neuraxial microstructural changes in a transgenic mouse model of early stage amyotrophic lateral sclerosis by ultra&#x2010;high field MRI and diffusion tensor metrics. Animal Model Exp Med. 2020;3:117&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323706</ArticleId><ArticleId IdType="pubmed">32613171</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi Y, Sato N, Saito Y, Kimura Y, Nakata Y, Ito K, et al. Usefulness of SWI for the detection of iron in the motor cortex in amyotrophic lateral sclerosis. J Neuroimaging. 2015;25:443&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">24888543</ArticleId></ArticleIdList></Reference><Reference><Citation>Meadowcroft MD, Mutic NJ, Bigler DC, Wang J&#x2010;L, Simmons Z, Connor JR, et al. Histological&#x2010;MRI correlation in the primary motor cortex of patients with amyotrophic lateral sclerosis. J Magn Reson Imaging. 2015;41:665&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4145061</ArticleId><ArticleId IdType="pubmed">24615949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JY, Jeong SY, Van Gelderen P, Deng H&#x2010;X, Quezado MM, Danielian LE, et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLOS ONE. 2012;7:e35241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328441</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Nairz M, Theurl I, Swirski FK, Weiss G. &#x201c;Pumping iron&#x201d;&#x2010;how macrophages handle iron at the systemic, microenvironmental, and cellular levels. Pflugers Arch. 2017;469(3&#x2013;4):397&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5362662</ArticleId><ArticleId IdType="pubmed">28251312</ArticleId></ArticleIdList></Reference><Reference><Citation>Sako W, Izumi Y, Abe T, Haji S, Murakami N, Osaki Y, et al. MR spectroscopy and imaging&#x2010;derived measurements in the supplementary motor area for biomarkers of amyotrophic lateral sclerosis. Neurol Sci. 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33594539</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Z, Chen Y, Yan G, Gang xiao, Shen Z, Wu R. Gang xiao, Zhiwei Shen, Renhua Wu. Progress of magnetic resonance imaging in amyotrophic lateral sclerosis. Radiol Infect Dis. 2019;6:1&#x2013;7.</Citation></Reference><Reference><Citation>Alam MM, Lee J, Lee SY. Recent progress in the development of TSPO PET ligands for neuroinflammation imaging in neurological diseases. Nucl Med Mol Imaging. 2017;51:283&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5721086</ArticleId><ArticleId IdType="pubmed">29242722</ArticleId></ArticleIdList></Reference><Reference><Citation>Block W, Karitzky J, Tr&#xe4;ber F, Pohl C, Keller E, Mundegar RR, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow&#x2010;up measurements. Arch Neurol. 1998;55:931&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9678310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen BC, Pattany PM, Bradley WG, Murdoch JB, Rotta F, Younis AA, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. Am J Neuroradiol. 2000;21:647&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7976640</ArticleId><ArticleId IdType="pubmed">10782773</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Boylan K, Jeromin A, Rutkove SB, Berry J, Atassi N, et al. ALS biomarkers for therapy development: state of the field and future directions. Muscle Nerve. 2016;53:169&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718795</ArticleId><ArticleId IdType="pubmed">26574709</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Zhang L, Wang L, Granit V, Statland J, Barohn R, et al. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology. 2020;95:e59&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371380</ArticleId><ArticleId IdType="pubmed">32385188</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P, Jardel C, Salachas F, Lamari F, Andersen PM, Bowser R, et al. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotroph Lateral Scler Frontotemp Degen. 2016;17(5&#x2013;6):404&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">27415180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C&#x2010;H, Macdonald&#x2010;Wallis C, Gray E, Pearce N, Petzold A, Norgren N, et al. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology. 2015;84:2247&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4456658</ArticleId><ArticleId IdType="pubmed">25934855</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C&#x2010;H, Petzold A, Topping JO, Allen K, Macdonald&#x2010;Wallis C, Clarke J, et al. Plasma neurofilament heavy chain levels and disease progression in amyotrophic lateral sclerosis: insights from a longitudinal study. J Neurol Neurosurg Psychiatry. 2015;86:565&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4413806</ArticleId><ArticleId IdType="pubmed">25009280</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos D, Moreau C, Kyheng M, Gar&#xe7;on G, Rolland AS, Blasco H, et al. A ferroptosis&#x2010;based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis. Sci Rep. 2019;9:2918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6393674</ArticleId><ArticleId IdType="pubmed">30814647</ArticleId></ArticleIdList></Reference><Reference><Citation>Swindell WR, Kruse CPS, List EO, Berryman DE, Kopchick JJ. ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia. J Transl Med. 2019;17:170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6530130</ArticleId><ArticleId IdType="pubmed">31118040</ArticleId></ArticleIdList></Reference><Reference><Citation>Winer L, Srinivasan D, Chun S, Lacomis D, Jaffa M, Fagan A, et al. SOD1 in cerebral spinal fluid as a pharmacodynamic marker for antisense oligonucleotide therapy. JAMA Neurol. 2013;70:201&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3812918</ArticleId><ArticleId IdType="pubmed">23147550</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, Simmons Z, et al. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology. 2009;72:14&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18987350</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P, Weydt P, Steinacker P, Anderl&#x2010;Straub S, Nordin F, Volk AE, et al. Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase. J Neurol Neurosurg Psychiatry. 2019;90:4&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">30224549</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu L, An J, Kovalik T, Gendron T, Petrucelli L, Bowser R. Cross&#x2010;sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes. J Neurol Neurosurg Psychiatry. 2020;91:350&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7147184</ArticleId><ArticleId IdType="pubmed">31937582</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray E, Thompson AG, Wuu J, Pelt J, Talbot K, Benatar M, et al. CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2020;7:1296&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448184</ArticleId><ArticleId IdType="pubmed">32666680</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepheard SR, Wuu J, Cardoso M, Wiklendt L, Dinning PG, Chataway T, et al. Urinary p75(ECD): A prognostic, disease progression, and pharmacodynamic biomarker in ALS. Neurology. 2017;88:1137&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373786</ArticleId><ArticleId IdType="pubmed">28228570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DH, Claussen GC, Oh S. Clinical nerve conduction and needle electromyography studies. J Am Acad Orthop Surg. 2004;12:276&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">15473679</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Cui X, Kim S, Wians R, Sorge R, Oh SJ, et al. Smads as muscle biomarkers in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2014;1:778&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4241805</ArticleId><ArticleId IdType="pubmed">25493269</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasca E, Pegoraro V, Merico A, Angelini C. Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS. Clin Neuropathol. 2016;35:22&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">26588026</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Bovio G, Canosa A, Bertuzzo D, Galmozzi F, et al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population&#x2010;based study. JAMA Neurol. 2014;71:1134&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">25048026</ArticleId></ArticleIdList></Reference><Reference><Citation>Offen D, Halevi S, Orion D, Mosberg R, Stern&#x2010;Goldberg H, Melamed E, et al. Antibodies from ALS patients inhibit dopamine release mediated by L&#x2010;type calcium channels. Neurology. 1998;51:1100&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">9781536</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano&#x2010;Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol. 2004;185:232&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagani MR, Gonzalez LE, Uchitel OD. Autoimmunity in amyotrophic lateral sclerosis: past and present. Neurol Res Int. 2011;2011:497080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3150148</ArticleId><ArticleId IdType="pubmed">21826267</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi FH, Lautrette C, Vermot&#x2010;Desroches C, Bordessoule D, Couratier P, Wijdenes J, et al. In vitro induction of neuronal apoptosis by anti&#x2010;Fas antibody&#x2010;containing sera from amyotrophic lateral sclerosis patients. J Neuroimmunol. 2000;109:211&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">10996223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordonez G, Sotelo J. Antibodies against fetal muscle proteins in serum from patients with amyotrophic lateral sclerosis. Neurology. 1989;39:683&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">2710359</ArticleId></ArticleIdList></Reference><Reference><Citation>Pestronk A, Adams RN, Clawson L, Cornblath D, Kuncl RW, Griffin D, et al. Serum antibodies to GM1 ganglioside in amyotrophic lateral sclerosis. Neurology. 1988;38:1457&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">3412595</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebroj&#x2010;Dobosz I, Janik P, Kwiecinski H. Serum IgM anti&#x2010;GM1 ganglioside antibodies in lower motor neuron syndromes. Eur J Neurol. 2004;11:13&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">14692882</ArticleId></ArticleIdList></Reference><Reference><Citation>Couratier P, Yi F&#x2010;H, Preud'homme J&#x2010;L, Clavelou P, White A, Sindou P, et al. Serum autoantibodies to neurofilament proteins in sporadic amyotrophic lateral sclerosis. J Neurol Sci. 1998;154:137&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">9562303</ArticleId></ArticleIdList></Reference><Reference><Citation>Fialov&#xe1; L, &#x160;varcov&#xe1; J, Bartos A, Ridzo&#x148; P, Malbohan I, Keller O, et al. Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2010;17:562&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19968709</ArticleId></ArticleIdList></Reference><Reference><Citation>Puentes F, Topping J, Kuhle J, van der Star BJ, Douiri A, Giovannoni G, et al. Immune reactivity to neurofilament proteins in the clinical staging of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2013;85:274&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24078718</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuyama Y, Mizuno T, Inoue H, Kimoto K. Amyotrophic lateral sclerosis with anti&#x2010;acetylcholine receptor antibody. Intern Med. 1997;36:312&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9187574</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 2001;57:1282&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11591849</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, Phatnani H, Kuligowski M, Tapia JC, Carrasco MA, Zhang M, et al. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc Natl Acad Sci USA. 2009;106:20960&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2791631</ArticleId><ArticleId IdType="pubmed">19933335</ArticleId></ArticleIdList></Reference><Reference><Citation>Graber DJ, Hickey WF, Harris BT. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J Neuroinflammation. 2010;7:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2825214</ArticleId><ArticleId IdType="pubmed">20109233</ArticleId></ArticleIdList></Reference><Reference><Citation>Troost D, Das PK, van den Oord JJ, Louwerse ES. Immunohistological alterations in muscle of patients with amyotrophic lateral sclerosis: mononuclear cell phenotypes and expression of MHC products. Clin Neuropathol. 1992;11:115&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">1611723</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves M, Fiala M, Dinglasan LA, Liu N, Sayre J, Chiappelli F, et al. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004;5:213&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">15799549</ArticleId></ArticleIdList></Reference><Reference><Citation>Troost D, Van den Oord JJ, Vianney de Jong JM. Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 1990;16:401&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">2263315</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi N, Kawano Y, Tateishi T, Kikuchi H, Osoegawa M, Ohyagi Y, et al. Increased IL&#x2010;13&#x2010;producing T cells in ALS: positive correlations with disease severity and progression rate. J Neuroimmunol. 2007;182(1&#x2013;2):232&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17097743</ArticleId></ArticleIdList></Reference><Reference><Citation>Provinciali L, Laurenzi MA, Vesprini L, Giovagnoli AR, Bartocci C, Montroni M, et al. Immunity assessment in the early stages of amyotrophic lateral sclerosis: a study of virus antibodies and lymphocyte subsets. Acta Neurol Scand. 1988;78:449&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">3265563</ArticleId></ArticleIdList></Reference><Reference><Citation>Consilvio C, Vincent AM, Feldman EL. Neuroinflammation, COX&#x2010;2, and ALS&#x2013;a dual role? Exp Neurol. 2004;187:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">15081582</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel JS, Engelhardt JI, Sikl&#xf3;s L, Simpson EP, Kim SH, Pan T, et al. Presence of dendritic cells, MCP&#x2010;1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004;55:221&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensley K, Abdel&#x2010;Moaty H, Hunter J, Mhatre M, Mou S, Nguyen K, et al. Primary glia expressing the G93A&#x2010;SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation. J Neuroinflammation. 2006;3:2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1360663</ArticleId><ArticleId IdType="pubmed">16436205</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelhardt JI, Tajti J, Appel SH. Lymphocytic infiltrates in the spinal cord in amyotrophic lateral sclerosis. Arch Neurol. 1993;50:30&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8093428</ArticleId></ArticleIdList></Reference><Reference><Citation>Saresella M, Piancone F, Tortorella P, Marventano I, Gatti A, Caputo D, et al. T helper&#x2010;17 activation dominates the immunologic milieu of both amyotrophic lateral sclerosis and progressive multiple sclerosis. Clin Immunol. 2013;148:79&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">23665549</ArticleId></ArticleIdList></Reference><Reference><Citation>Troost D, van den Oord JJ, de Jong JM, Swaab DF. Lymphocytic infiltration in the spinal cord of patients with amyotrophic lateral sclerosis. Clin Neuropathol. 1989;8:289&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">2533530</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, Moglia C, Balma M, Chio A. Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: a therapeutic opportunity? CNS Neurol Disord Drug Targets. 2010;9:325&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">20406178</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M, Evangelopoulos E, Sereti E, Zouvelou V, Marmara S, Alexakis T, et al. Alterations of T cell subsets in ALS: a systemic immune activation? Acta Neurol Scand. 2011;125:260&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">21651502</ArticleId></ArticleIdList></Reference><Reference><Citation>Italiani P, Carlesi C, Giungato P, Puxeddu I, Borroni B, Boss&#xf9; P, et al. Evaluating the levels of interleukin&#x2010;1 family cytokines in sporadic amyotrophic lateral sclerosis. J Neuroinflammation. 2014;11:94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4039322</ArticleId><ArticleId IdType="pubmed">24884937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S, Hu J, Shimizu N, Imai T, Nakagawa H. Increased interleukin&#x2010;6 of skin and serum in amyotrophic lateral sclerosis. J Neurol Sci. 2001;187:27&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">11440741</ArticleId></ArticleIdList></Reference><Reference><Citation>Rentzos M, Nikolaou C, Rombos A, Boufidou F, Zoga M, Dimitrakopoulos A, et al. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:283&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">17852013</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G&#x2010;T, Hwang C&#x2010;S, Hsieh C&#x2010;H, Lu C&#x2010;H, Chang S&#x2010;Y, Lee J&#x2010;C, et al. Eosinophil&#x2010;derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis. Mediators Inflamm. 2013;2013:421389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590756</ArticleId><ArticleId IdType="pubmed">23533305</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahia El Idrissi N, Bosch S, Ramaglia V, Aronica E, Baas F, Troost D. Complement activation at the motor end&#x2010;plates in amyotrophic lateral sclerosis. J Neuroinflamm. 2016;13:72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4823861</ArticleId><ArticleId IdType="pubmed">27056040</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M, Shimohama S. The role of nitric oxide in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2001;2:71&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">11675875</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensley K, Mhatre M, Mou S, Pye QN, Stewart C, West M, et al. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A&#x2010;SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid Redox Signal. 2006;8:2075&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">17034351</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamata T, Akiyama H, Yamada T, McGeer PL. Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. Am J Pathol. 1992;140:691&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1886170</ArticleId><ArticleId IdType="pubmed">1347673</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed HA, Mosier DR, Zou LL, Siklos L, Alexianu ME, Engelhardt JI, et al. Immunoglobulin Fc gamma receptor promotes immunoglobulin uptake, immunoglobulin&#x2010;mediated calcium increase, and neurotransmitter release in motor neurons. J Neurosci Res. 2002;69:110&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111822</ArticleId></ArticleIdList></Reference><Reference><Citation>Coque E, Salsac C, Espinosa&#x2010;Carrasco G, Varga B, Degauque N, Cadoux M, et al. Cytotoxic CD8(+) T lymphocytes expressing ALS&#x2010;causing SOD1 mutant selectively trigger death of spinal motoneurons. Proc Natl Acad Sci USA. 2019;116:2312&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6369778</ArticleId><ArticleId IdType="pubmed">30674678</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Goutman SA, Boss J, Kim S, Feldman EL. Amyotrophic lateral sclerosis survival associates with neutrophils in a sex&#x2010;specific manner. Neurol Neuroimmunol Neuroinflamm. 2021;8:e953.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057067</ArticleId><ArticleId IdType="pubmed">33531377</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiarotto GB, Nardo G, Trolese MC, Franca MC Jr, Bendotti C, Rodrigues de Oliveira AL. The emerging role of the major histocompatibility complex class I in amyotrophic lateral sclerosis. Int J Mol Sci. 2017;18:2298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5713268</ArticleId><ArticleId IdType="pubmed">29104236</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoser BG, Wehling S, Blottner D. Cell death and apoptosis&#x2010;related proteins in muscle biopsies of sporadic amyotrophic lateral sclerosis and polyneuropathy. Muscle Nerve. 2001;24:1083&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11439385</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H, Noto Y&#x2010;I, Makita N, Kushimura&#x2010;Okada Y, Ishii R, Tanaka A, et al. Myasthenic symptoms in anti&#x2010;low&#x2010;density lipoprotein receptor&#x2010;related protein 4 antibody&#x2010;seropositive amyotrophic lateral sclerosis: two case reports. BMC Neurol. 2016;16:229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5116211</ArticleId><ArticleId IdType="pubmed">27863479</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>